Table 1.
Summaries of participant clinical characteristics, activity measures, and change in cystic fibrosis quality of life measures.
|
Overall
N = 16 |
IV pump type | ||
|---|---|---|---|
|
Spring-infusor
N = 9 |
Standard infusion
N = 7 |
||
| Demographic and clinical characteristics | |||
| Age (years) | 14.47 (2.90) | 15.67 (2.38) | 12.93 (2.91) |
| Initial 1FEV1 (%) | 80 (17) | 86 (11) | 72 (20) |
| Change from admission in 1FEV1 (%) | 8 (9) | 4 (8) | 12 (8) |
| Length of stay (days) | 14.1 (3.5) | 12.4 (1.7) | 16.1 (4.3) |
| 2 Activity measures | |||
| Average step count | 4806 (3,116) | 5324 (2873) | 4139 (3512) |
| Sleep time (hours)_ave | 9.06 (1.29) | 9.00 (1.71) | 9.14 (0.50) |
| Number of sit_stand_ave | 37 (18) | 37 (10) | 37 (25) |
| Standing (hours) | 1.96 (0.99) | 2.22 (0.74) | 1.61 (1.23) |
| Change in 3CFQ-R scores (discharge–admission) | N = 13 | N = 7 | N = 6 |
| Treatment burden | −3 (23) | 3 (25) | −11 (20) |
| Respiratory | 2 (16) | 3 (12) | 0 (21) |
| Physical | −6 (17) | −3 (7) | −9 (26) |
| Emotion | 1 (11) | 4 (5) | −3 (16) |
Note: Values are mean (standard deviation).
1FEV1: forced expiratory volume as a percent of predicted volume.
2Obtained from an ActivPAL4 activity monitor.
3CFQ-R: cystic fibrosis quality of life questionnaire.